Ted Gooley

Ted Gooley, PhD, is a Professor in the Clinical Research Division and Public Health Sciences Division at Fred Hutchinson Cancer Center, where he serves as Director of the Clinical Biostatistics Program and Biostatistics Shared Resource. His leadership supports statistical analysis for hundreds of global clinical trials and observational studies across oncology and autoimmune diseases.

Dr. Gooley's educational background includes:

• BA in Mathematics from Washington State University (1984)
• PhD in Applied Mathematics from the University of Arizona (1990)

A leading biostatistician, Dr. Gooley specializes in laboratory research design, clinical trial methodology, and observational study analysis. His work drives advancements in hematopoietic cell transplantation outcomes, rheumatology therapeutics, and solid tumor oncology through innovative statistical frameworks. He has contributed to landmark studies improving survival rates for blood cancer patients and optimizing transplant protocols.

His publication record includes highly influential biostatistical methods, exemplified by a 1999 Statistics in Medicine paper ranking among the top 25 most-cited applied biostatistics works from 1985-2002. This research established foundational approaches for survival analysis in clinical contexts.

No formal scientific awards are documented in the source materials.

Dr. Gooley mentors the next generation of researchers through teaching biostatistics to hematology/oncology fellows and co-instructing a summer curriculum for blood stem cell transplantation clinicians. His grant-funded initiatives focus on statistical infrastructure for large-scale cancer immunotherapy trials and transplantation refinements.

He directs the Biostatistics Shared Resource and Clinical Biostatistics Program, leading teams that provide critical statistical support for Fred Hutch's clinical research enterprise including CAR T-cell therapy development, metastatic cancer studies, and psilocybin clinical trials for healthcare worker mental health.